Increased metabolism in the R6/2 mouse model of Huntington's disease.
about
Early alterations of brain cellular energy homeostasis in Huntington disease modelsMouse models of polyglutamine diseases: review and data table. Part IResponses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's diseaseShaping the role of mitochondria in the pathogenesis of Huntington's diseaseComprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocyclineDecreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression.Proliferative hypothalamic neurospheres express NPY, AGRP, POMC, CART and Orexin-A and differentiate to functional neurons.Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.Beneficial effects of environmental enrichment and food entrainment in the R6/2 mouse model of Huntington's disease.No evidence of impaired gastric emptying in early Huntington's Disease.Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 miceDelayed Onset and Reduced Cognitive Deficits through Pre-Conditioning with 3-Nitropropionic Acid is Dependent on Sex and CAG Repeat Length in the R6/2 Mouse Model of Huntington's Disease.Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease.Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's diseaseEvidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington's Disease.Measures of growth in children at risk for Huntington diseaseEuglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's DiseaseAdipose tissue dysfunction tracks disease progression in two Huntington's disease mouse modelsEnergy deficit in Huntington disease: why it matters.Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models.Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling.Body weight is a robust predictor of clinical progression in Huntington disease.Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.Mutant huntingtin fragment selectively suppresses Brn-2 POU domain transcription factor to mediate hypothalamic cell dysfunctionDietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington's disease.Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's diseaseGrowth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease.Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease.Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.Hypocretin and melanin-concentrating hormone in patients with Huntington disease.Neuropeptide alterations in the infundibular nucleus of Huntington's disease patients.Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice.Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington's Disease.Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism.Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington's Disease.
P2860
Q23912810-62B5A05A-9A58-440F-AB46-F9D212ABFD50Q26853025-983533BA-91B8-4B95-9ABA-10A654CF62F2Q27334872-FD6FAB43-DAE6-424A-B03D-AD240B95E8FBQ28384036-AF15D398-0B6C-4588-8BCB-CE406527AA13Q28748449-E1201F88-9605-44B3-A625-D0A0DA0685E6Q30542392-16F63E52-6A7A-46E6-A03B-BD3A7FA1CC13Q31011157-C5D0BE39-CF93-49FE-A223-E681C904CF51Q33517121-6DFF9746-D6BD-47E9-AC51-83B8C095E905Q33935845-C3374631-351A-4873-B00E-2FA40FA529C9Q34087126-E6BB5A5E-247C-4A5A-9A9F-987616E03A16Q34459323-C5901591-8D84-4AC9-90D3-7C5F404AB85EQ34520437-C5E25967-5D2E-46E4-B10F-47C6FDF62DF0Q35058593-C24215AE-EC85-4ACE-9BF8-50F9C321A35DQ35086831-CA65DEEA-1E1C-447B-82C9-E3C75F794AE1Q35754248-6091A62C-3E3D-41AA-884D-969F7014BCEFQ36093756-2F9AB417-7950-4A0E-B13D-8F0D9FDD3414Q36149988-6E979507-C23A-4A7B-B174-0494418350E7Q36234711-89F7041B-3946-4F22-88AB-C6032550B0B7Q37089398-7A932CD3-84CB-4615-A47A-B5F695354240Q37112122-A21D79BB-E59A-4F4D-8967-70AC504E8BFAQ37834195-D5FA85BD-E09A-4A49-84D9-C2BD9EADA1B5Q38235229-A77AB610-D985-4E0E-B76D-E9EE33161A69Q38458943-107D7011-B2D0-4DCA-B847-E91419632D65Q38639328-F62EBDD6-F0FE-426B-ABA2-A678800D3B13Q38654045-4774ACAE-183F-419D-8730-115AD85644FBQ38993673-02134289-08E6-4083-8EB4-1514B21CECCBQ39629256-CA0ACF57-1794-4752-B53B-7CB737EF61EFQ40392188-E9A2E527-4B01-4926-A58B-EFCB5794822CQ41734464-2D9A7B3C-BF02-4C0B-96A6-0DA59CB9CE18Q42577971-8EA7F48A-D1B4-4E60-97D5-45354BB2E226Q43257519-1E31200A-CB91-48EC-8410-4ADAFE2F32E3Q43314674-B4B21D6D-EA32-4EDD-89A0-9D2F3882DF82Q44250471-310089C4-5472-4E56-A2DF-D33A304E33B6Q45289637-3F830350-E0A2-4578-9572-D576CDBE1778Q45289739-684CE737-62F5-4EEC-9674-48C3BA50D345Q45290567-5821DC07-FD2B-4065-8ECD-203446B70CBBQ45292519-64BE3821-4C40-46F9-A50F-3883AF67FA3FQ49659203-3695C095-1D27-4A57-AF33-4FA7F478A25FQ55295842-08B7F996-89A5-4DF0-846F-02579B9A3A17
P2860
Increased metabolism in the R6/2 mouse model of Huntington's disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Increased metabolism in the R6/2 mouse model of Huntington's disease.
@ast
Increased metabolism in the R6/2 mouse model of Huntington's disease.
@en
Increased metabolism in the R6/2 mouse model of Huntington's disease.
@nl
type
label
Increased metabolism in the R6/2 mouse model of Huntington's disease.
@ast
Increased metabolism in the R6/2 mouse model of Huntington's disease.
@en
Increased metabolism in the R6/2 mouse model of Huntington's disease.
@nl
prefLabel
Increased metabolism in the R6/2 mouse model of Huntington's disease.
@ast
Increased metabolism in the R6/2 mouse model of Huntington's disease.
@en
Increased metabolism in the R6/2 mouse model of Huntington's disease.
@nl
P2093
P50
P1476
Increased metabolism in the R6/2 mouse model of Huntington's disease
@en
P2093
Andreas Lindqvist
Asa Petersén
Ben Woodman
Jaclyn I Wamsteeker
Jorien M M van der Burg
Michael J Kuhar
Nigel I Wood
Nils Wierup
Patrik Brundin
Tomas Deierborg
P356
10.1016/J.NBD.2007.07.029
P50
P577
2007-08-24T00:00:00Z